Co-Founder
CurrentAt HOVANA, we're powering new possibilities in human health by tackling translational dysfunction as a driver of serious diseases. Leveraging unprecedented insights into tRNA reprogramming, HOVANA is inventing a new class of genomic medicines that correct translation of disease-causing proteins.Led by a team whose work has generated 12 registered therapeutics, and founded by pioneers in tRNA research at MIT, Harvard and The RNA Institute, HOVANA is harmonizing expertise across functional genomics, multi-omics and computation to drug a previously untapped layer of biological regulation in complex, multigenic diseases like cancer.